BR100 Increased By (1.37%)
BR30 Increased By (1.26%)
KSE100 Increased By (1.07%)
KSE30 Increased By (1.11%)
AGHA 7.83 Increased By ▲ 0.08 (1.03%)
BECO 5.24 Increased By ▲ 0.05 (0.96%)
BML 57.80 Decreased By ▼ -0.86 (-1.47%)
BOP 34.40 Increased By ▲ 0.71 (2.11%)
CNERGY 10.91 Increased By ▲ 0.30 (2.83%)
CSIL 5.45 Increased By ▲ 0.15 (2.83%)
FCCL 55.00 Increased By ▲ 1.26 (2.34%)
FFL 16.82 Increased By ▲ 0.36 (2.19%)
FNEL 1.25 Increased By ▲ 0.03 (2.46%)
KEL 7.43 Increased By ▲ 0.15 (2.06%)
KOSM 5.84 Increased By ▲ 0.20 (3.55%)
LOTCHEM 30.00 Increased By ▲ 0.35 (1.18%)
MLCF 96.56 Increased By ▲ 0.20 (0.21%)
NBP 206.20 Increased By ▲ 2.67 (1.31%)
NCPL 58.00 Increased By ▲ 1.15 (2.02%)
NPL 69.00 Increased By ▲ 1.69 (2.51%)
OGDC 319.99 Increased By ▲ 1.77 (0.56%)
PACE 10.94 Increased By ▲ 0.31 (2.92%)
PAEL 43.35 Increased By ▲ 1.58 (3.78%)
PIBTL 17.08 Increased By ▲ 0.27 (1.61%)
PPL 222.80 Increased By ▲ 2.63 (1.19%)
PRL 52.45 Increased By ▲ 3.40 (6.93%)
PTC 71.80 Increased By ▲ 1.79 (2.56%)
SSGC 29.63 Increased By ▲ 0.49 (1.68%)
TBL 9.93 Increased By ▲ 0.16 (1.64%)
TELE 8.96 Increased By ▲ 0.14 (1.59%)
TPL 17.88 Increased By ▲ 0.71 (4.14%)
TPLP 13.05 Increased By ▲ 0.54 (4.32%)
TREET 22.95 Increased By ▲ 0.36 (1.59%)
TRG 60.35 Increased By ▲ 0.13 (0.22%)
World

AstraZeneca shot is good if safety issues can be overcome, US official Fauci says

  • "I think that the AstraZeneca vaccine from a standpoint of efficacy is a good vaccine, and if the safety issue gets straightened out in the European Union... the efficacy of that vaccine is really quite good," he told BBC radio on Tuesday.
Published Updated
By

LONDON: US infectious disease official Anthony Fauci said if safety concerns about AstraZeneca's COVID-19 vaccine were straightened out it had good efficacy, but it might not be needed for Americans because of supplies of other shots.

"I think that the AstraZeneca vaccine from a standpoint of efficacy is a good vaccine, and if the safety issue gets straightened out in the European Union... the efficacy of that vaccine is really quite good," he told BBC radio on Tuesday.

"Whether or not we ever use AZ is unclear but it looks right now at this point in time that we will not need it. It's not a negative indictment of AZ, it is just possible that given the supply that we have from other companies that we may not need to use an AZ vaccine."

The AstraZeneca vaccine is being investigated by European regulators over concerns about rare cases of blood clots. It has not yet been approved in the United States.

Comments

Comments are closed for this article.